236 related articles for article (PubMed ID: 11282270)
1. In vitro activity of four fluoroquinolones against Mycobacterium tuberculosis.
Rodríguez JC; Ruiz M; Climent A; Royo G
Int J Antimicrob Agents; 2001 Mar; 17(3):229-31. PubMed ID: 11282270
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis.
Rodríguez JC; Ruiz M; López M; Royo G
Int J Antimicrob Agents; 2002 Dec; 20(6):464-7. PubMed ID: 12458143
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the bactericidal activity of various fluoroquinolones against Mycobacterium tuberculosis in an in vitro experimental model.
Cremades R; Rodríguez JC; García-Pachón E; Galiana A; Ruiz-García M; López P; Royo G
J Antimicrob Chemother; 2011 Oct; 66(10):2281-3. PubMed ID: 21733966
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of fluoroquinolones against Mycobacterium tuberculosis.
Sulochana S; Rahman F; Paramasivan CN
J Chemother; 2005 Apr; 17(2):169-73. PubMed ID: 15920901
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activity of three fluoroquinolones against clinical isolates by E test.
Madhusudhan KT; Counts C; Lody C; Carter O; Dodson S; Ojha N
Chemotherapy; 2003 Jul; 49(4):184-8. PubMed ID: 12886053
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of five fluoroquinolones by Mycobacterium tuberculosis H37Rv.
Piddock LJ; Ricci V
J Antimicrob Chemother; 2001 Dec; 48(6):787-91. PubMed ID: 11733462
[TBL] [Abstract][Full Text] [Related]
7. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.
Kowalski RP; Dhaliwal DK; Karenchak LM; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
Am J Ophthalmol; 2003 Sep; 136(3):500-5. PubMed ID: 12967804
[TBL] [Abstract][Full Text] [Related]
8. Activity of moxifloxacin and other quinolones against pneumococci resistant to first-line agents, or with high-level ciprofloxacin resistance.
Johnson AP; Warner M; Livermore DM
Int J Antimicrob Agents; 2001 May; 17(5):377-81. PubMed ID: 11337224
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the bactericidal activity of quinolone antibiotics in a Mycobacterium fortuitum model.
Gillespie SH; Morrissey I; Everett D
J Med Microbiol; 2001 Jun; 50(6):565-570. PubMed ID: 11393294
[TBL] [Abstract][Full Text] [Related]
10. Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data.
Angeby KA; Jureen P; Giske CG; Chryssanthou E; Sturegård E; Nordvall M; Johansson AG; Werngren J; Kahlmeter G; Hoffner SE; Schön T
J Antimicrob Chemother; 2010 May; 65(5):946-52. PubMed ID: 20332195
[TBL] [Abstract][Full Text] [Related]
11. Multicentre study of the in vitro evaluation of moxifloxacin and other quinolones against community acquired respiratory pathogens.
Lopez H; Vilches V; Scarano S; Stepanik D; Smayevsky J; Lemme L; Cardeñosa O; Ambler J; Sucari A
Int J Antimicrob Agents; 2001 Oct; 18(4):379-82. PubMed ID: 11691572
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of ciprofloxacin, ofloxacin and levofloxacin against Mycobacterium tuberculosis.
Akcali S; Surucuoglu S; Cicek C; Ozbakkaloglu B
Ann Saudi Med; 2005; 25(5):409-12. PubMed ID: 16270765
[TBL] [Abstract][Full Text] [Related]
13. Comparative activities of ciprofloxacin, clinafloxacin, gatifloxacin, gemifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against epidemiologically defined Acinetobacter baumannii strains.
Heinemann B; Wisplinghoff H; Edmond M; Seifert H
Antimicrob Agents Chemother; 2000 Aug; 44(8):2211-3. PubMed ID: 10898706
[TBL] [Abstract][Full Text] [Related]
14. Induction of mycobacterial resistance to quinolone class antimicrobials.
Malik M; Chavda K; Zhao X; Shah N; Hussain S; Kurepina N; Kreiswirth BN; Kerns RJ; Drlica K
Antimicrob Agents Chemother; 2012 Jul; 56(7):3879-87. PubMed ID: 22564842
[TBL] [Abstract][Full Text] [Related]
15. Comparative antimicrobial activities of the newly synthesized quinolone WQ-3034, levofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
Tomioka H; Sato K; Kajitani H; Akaki T; Shishido S
Antimicrob Agents Chemother; 2000 Feb; 44(2):283-6. PubMed ID: 10639351
[TBL] [Abstract][Full Text] [Related]
16. Ciprofloxacin- and methicillin-resistant staphylococcus aureus susceptible to moxifloxacin, levofloxacin, teicoplanin, vancomycin and linezolid.
Presterl E; Mueller-Uri P; Grisold A; Georgopoulos A; Graninger W
Eur J Clin Microbiol Infect Dis; 2001 Jul; 20(7):486-9. PubMed ID: 11561805
[TBL] [Abstract][Full Text] [Related]
17. Single- and multistep selection study of the antipneumococcal activity of BMS-284756 compared to ciprofloxacin, levofloxacin, trovafloxacin and moxifloxacin.
Clark CL; Nagai K; Davies TA; Bozdogan B; Dewasse B; Jacobs MR; Appelbaum PC
Clin Microbiol Infect; 2002 Jun; 8(6):373-80. PubMed ID: 12084107
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial activity of moxifloxacin (Bay 12-8039) against aerobic clinical isolates, and provisional criteria for disk susceptibility tests.
Barry AL; Fuchs PC; Brown SD
Eur J Clin Microbiol Infect Dis; 1999 Apr; 18(4):305-9. PubMed ID: 10385024
[TBL] [Abstract][Full Text] [Related]
19. Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-resistant and -susceptible Staphylococcus aureus strains.
Jones ME; Visser MR; Klootwijk M; Heisig P; Verhoef J; Schmitz FJ
Antimicrob Agents Chemother; 1999 Feb; 43(2):421-3. PubMed ID: 9925551
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of Legionella spp.
Gómez-Lus R; Adrián F; del Campo R; Gómez-Lus P; Sánchez S; García C; Rubio MC
Int J Antimicrob Agents; 2001 Jul; 18(1):49-54. PubMed ID: 11463526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
